Novel approaches to the treatment of chronic graft-versus-host disease

Expert Opinion on Investigational Drugs
D Gaziev, G Lucarelli

Abstract

Chronic graft-versus-host disease (cGvHD) continues to be the major problem in long-term survivors of allogeneic haematopoietic stem cell transplants and is the principal cause of morbidity and non-relapse mortality. Over the past twenty years, diagnosis, prophylaxis and treatment of cGvHD have slowly evolved. An effective therapy for cGvHD is designed to prevent complications through targeting the disease mechanisms. None of the present therapies for cGvHD are successful in the majority of patients. Conventional drugs in different combinations can control the disease in approximately 50% of patients. Attempts to improve survival have led to evaluation of several alternative approaches in the treatment of refractory cGvHD with varying degrees of success. Clinical trials are needed to establish the role of these new approaches in the treatment of cGvHD as first line or salvage therapy without causing significant side effects. This review summarises the currently available knowledge on conventional and new treatment approaches for cGvHD.

References

Jun 1, 1979·Photochemistry and Photobiology·P S Song, K J Tapley
Sep 1, 1978·The British Journal of Dermatology·T Chuaprapaisilp, T Piamphongsant
Apr 15, 1992·Annals of Internal Medicine·R H FriedG B McDonald
Apr 16, 1992·The New England Journal of Medicine·G B VogelsangJ R Wingard
Apr 1, 1992·Transplantation·M R Costanzo-NordinJ A Robinson
Nov 1, 1991·Archives of Dermatology·R M JampelW L Morison
Mar 7, 1991·The New England Journal of Medicine·J L Ferrara, H J Deeg
May 1, 1991·British Journal of Haematology·D HeneyD L Barnard
Aug 1, 1990·Journal of the American Academy of Dermatology·B Volc-PlatzerK Wolff
Feb 15, 1990·The New England Journal of Medicine·G LucarelliF Albertini
Jan 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·S C GarnerS U Toverud
Mar 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D D ThompsonG A Rodan
Apr 1, 1990·British Journal of Haematology·B LönnqvistO Ringdén
Jan 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y CalmusR Poupon
Feb 1, 1989·Clinical Pharmacokinetics·M R Holdiness
Jul 28, 1986·The American Journal of Medicine·J D Meyers
Feb 5, 1987·The New England Journal of Medicine·R EdelsonG Plewig
Jul 1, 1974·The British Journal of Dermatology·J P Mackey, J Barnes
Jan 1, 1983·Clinical and Laboratory Haematology·G P SummerfieldJ C Woodrow
Aug 1, 1980·The American Journal of Medicine·H M ShulmanE D Thomas
May 1, 1981·Archives of Dermatology·F Crovato, L Levi
Sep 1, 1994·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·G I FegerM Wahl
Sep 1, 1994·Journal of the American Academy of Dermatology·J S Altman, S S Adler
Oct 1, 1993·Seminars in Arthritis and Rheumatism·R I Fox
Jun 1, 1993·The Journal of Experimental Medicine·A L MoreiraG Kaplan
Nov 16, 1996·Lancet·J J Lipsky

❮ Previous
Next ❯

Citations

Feb 2, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Matin M ImanguliJane C Atkinson
Aug 2, 2003·Organic Letters·Scott M CapitostiMilton L Brown
Jan 16, 2004·Bioorganic & Medicinal Chemistry·Scott M CapitostiMilton L Brown
Mar 7, 2003·Bone Marrow Transplantation·E BisacciaS L Goldberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.